Healthcare & Life Sciences
ALX Oncology
United Statesalxoncology.com
ALX Oncology is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 2 tracked investors.
Activeseries-c-plus
series-c-plus
Stage
2018
Founded
2
Investors
About ALX Oncology
ALX Oncology is a startup founded in 2018 based in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
ALX Oncology is a clinical-stage immuno-oncology company focused on developing therapies that block the CD47 checkpoint pathway to help patients fight cancer.
Explore ALX Oncology's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.